222 related articles for article (PubMed ID: 33717617)
1. Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines.
Tousi MS; Sepehri H; Khoee S; Farimani MM; Delphi L; Mansourizadeh F
J Pharm Anal; 2021 Feb; 11(1):108-121. PubMed ID: 33717617
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
4. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
5. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, purification, and anticancer effect of magnetic Fe
Wang K; Hu H; Zhang Q; Zhang Y; Shi C
J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells.
Nassir AM; Shahzad N; Ibrahim IAA; Ahmad I; Md S; Ain MR
Saudi Pharm J; 2018 Sep; 26(6):876-885. PubMed ID: 30202231
[TBL] [Abstract][Full Text] [Related]
9. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
Liu H; Xu H; Zhang C; Gao M; Gao X; Ma C; Lv L; Gao D; Deng S; Wang C; Tian Y
Pharm Res; 2016 Nov; 33(11):2828-43. PubMed ID: 27511028
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line.
Hajikarimi Z; Khoei S; Khoee S; Mahdavi SR
IEEE Trans Nanobioscience; 2014 Dec; 13(4):403-8. PubMed ID: 25051558
[TBL] [Abstract][Full Text] [Related]
12. [Anti-CD206 antibody-conjugated Fe
Fu Q; Tang H; Zhang P; Que K; Liu Z; Zhou Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):246-254. PubMed ID: 32376536
[TBL] [Abstract][Full Text] [Related]
13. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
Katsikogianni G; Avgoustakis K
J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD206 antibody-conjugated Fe
Zhou Y; Que KT; Tang HM; Zhang P; Fu QM; Liu ZJ
Oncol Lett; 2020 Dec; 20(6):298. PubMed ID: 33101492
[TBL] [Abstract][Full Text] [Related]
16. Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer.
Sedki M; Khalil IA; El-Sherbiny IM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S641-S650. PubMed ID: 30295086
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo.
Paul A; Das S; Das J; Samadder A; Khuda-Bukhsh AR
Toxicol Lett; 2013 Sep; 222(1):10-22. PubMed ID: 23850776
[TBL] [Abstract][Full Text] [Related]
18. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
19. Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles.
Liu X; Zhang M; Tian Y; Liu R; Wang Y; Guo F; Gong Y; Yan M
AAPS PharmSciTech; 2022 Mar; 23(4):100. PubMed ID: 35348949
[TBL] [Abstract][Full Text] [Related]
20. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
